DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Insurance
Updated 6h ago
CS logo

AXA SAENXTPA:CS Stock Report

Market Cap €88.3b
Updated 6h ago
Share Price
n/a
1Y11.7%
7D3.0%
1D1.4%
Portfolio Value
​
View

AXA SA

ENXTPA:CS Stock Report

Market Cap: €88.3b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

AXA (CS) Stock Overview

Through its subsidiaries, provides insurance, asset management, and banking services worldwide. More details

CS fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health4/6
Dividends4/6

Rewards

Trading at 54.8% below our estimate of its fair value

Earnings are forecast to grow 6.24% per year

Earnings have grown 4.9% per year over the past 5 years

Risk Analysis

Unstable dividend track record


CS Community Fair Values

Create Narrative

See what 160 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
8.9% undervalued intrinsic discount
AnalystConsensusTarget
•2mo ago

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

519
0
95
AN
AnalystHighTarget
33.2% undervalued intrinsic discount
AnalystHighTarget
•13d ago

AI And Climate Risk Tailwinds Will Reshape This Global Insurer’s Next Decade

50
0
1
AN
AnalystLowTarget
4.3% overvalued intrinsic discount
AnalystLowTarget
•1mo ago

Climate And Aging Trends Will Shape Insurance Demand While Returns Stay Steady

36
0
1

Top Analyst Narratives

AN
AnalystConsensusTarget
8.9% undervalued intrinsic discount
AnalystConsensusTarget
•2mo ago

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

519
0
95
AN
AnalystHighTarget
33.2% undervalued intrinsic discount
AnalystHighTarget
•13d ago

AI And Climate Risk Tailwinds Will Reshape This Global Insurer’s Next Decade

50
0
1
AN
AnalystLowTarget
4.3% overvalued intrinsic discount
AnalystLowTarget
•1mo ago

Climate And Aging Trends Will Shape Insurance Demand While Returns Stay Steady

36
0
1
View all narratives

AXA SA Competitors

Zurich Insurance Group

Symbol: SWX:ZURN
Market cap: CHF 89.7b

Assicurazioni Generali

Symbol: BIT:G
Market cap: €69.4b

SCOR

Symbol: ENXTPA:SCR
Market cap: €5.9b

Allianz

Symbol: XTRA:ALV
Market cap: €168.1b

Price History & Performance

Summary of share price highs, lows and changes for AXA
Historical stock prices
Current Share Price€44.21
52 Week High€45.66
52 Week Low€36.55
Beta0.58
1 Month Change-0.90%
3 Month Change4.27%
1 Year Change11.73%
3 Year Change50.63%
5 Year Change91.84%
Change since IPO2,238.82%

Recent News & Updates

User avatar
Narrative Update • Sep 03

CS: Higher Earnings Multiple Will Be Supported By AI Governance Progress

Analysts have lifted the fair value estimate for AXA to €66.18 from €64.68, reflecting higher Street price targets that now reach up to €77.10 as they point to updated assumptions on revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on AXA points to a cluster of higher price targets and supportive ratings that highlight constructive views on the stock.
User avatar
Narrative Update • Aug 13

CS: Raised Price Views Will Support A Higher Future Earnings Multiple

AXA’s updated analyst price target has risen to €64.68 from €62.41. This reflects adjustments in fair value, discount rate, revenue growth, profit margin and future P/E that are broadly consistent with recent target increases from several research firms.

Recent updates

User avatar
Narrative Update • Sep 03

CS: Higher Earnings Multiple Will Be Supported By AI Governance Progress

Analysts have lifted the fair value estimate for AXA to €66.18 from €64.68, reflecting higher Street price targets that now reach up to €77.10 as they point to updated assumptions on revenue growth, profit margins and future P/E multiples. Analyst Commentary Recent Street research on AXA points to a cluster of higher price targets and supportive ratings that highlight constructive views on the stock.
User avatar
Narrative Update • Aug 13

CS: Raised Price Views Will Support A Higher Future Earnings Multiple

AXA’s updated analyst price target has risen to €64.68 from €62.41. This reflects adjustments in fair value, discount rate, revenue growth, profit margin and future P/E that are broadly consistent with recent target increases from several research firms.
User avatar
Narrative Update • Jul 30

CS: Higher Revenue Assumptions And Lower Discount Rate Will Test Execution

AXA's analyst price target has increased to €42.40 from €40.00, with analysts citing updated assumptions for revenue growth, margins, P/E and discount rates that are broadly consistent with recent upward revisions to Street targets in the range of approximately €50 to €77.10 per share. Analyst Commentary Recent Street research on AXA shows a wide spread in price targets, ranging from around €50 to €77.10 per share.
User avatar
Narrative Update • Jul 16

CS: Updated Fair Value And P/E Assumptions Will Shape Balanced Re Rating

AXA's analyst price target has been nudged higher to €50, with analysts pointing to slightly adjusted fair value estimates, updated revenue growth and margin assumptions, and modestly refined future P/E expectations as key factors supporting the change. Analyst Commentary Recent research commentary on AXA points to a mixed but generally constructive view, with several price target increases and one reduction reflecting different opinions on valuation, growth assumptions, and execution risk.
User avatar
New Narrative • Jun 30

Climate And Aging Trends Will Shape Insurance Demand While Returns Stay Steady

Catalysts About AXA AXA is a global insurance group offering property and casualty, life, health, savings and retirement products to retail clients, businesses and institutions. What are the underlying business or industry changes driving this perspective?
User avatar
Narrative Update • Jun 18

CS: Higher Fair Value And P/E Assumptions Will Support Measured Re Rating

Analysts have nudged the fair value estimate for AXA higher to €47.51 from €46.48, citing a series of upward revisions to price targets, including recent increases to around €77.10 from €57.40 and by €1 in other Street updates, alongside broadly supportive new coverage. Analyst Commentary Recent Street research on AXA offers a mix of optimism and caution that investors can weigh against the revised fair value estimate.
User avatar
New Narrative • Jun 15

AI And Climate Risk Tailwinds Will Reshape This Global Insurer’s Next Decade

Catalysts About AXA AXA is a global insurance group active in Property & Casualty, Life, Health, Savings and reinsurance across Europe, Asia, Africa and other markets. What are the underlying business or industry changes driving this perspective?
User avatar
Narrative Update • Jun 03

CS: Higher Fair Value And P/E Assumptions Will Support Measured Re Rating

AXA's analyst price target has edged higher by about €0.35, with analysts pointing to modestly revised assumptions around fair value, discount rate, profit margin and future P/E. This move is supported by recent research that includes both a €1 target increase and a €1 reduction from different banks, alongside a bullish initiation.
User avatar
Narrative Update • May 08

CS: Technical And Fee-Based Shift Plus Buybacks Will Support Measured Re-Rating

AXA's fair value estimate edges higher to €46.12 from €46.07 as analysts refine assumptions around revenue growth, profit margins and future P/E, supported by a series of recent price target increases and bullish initiations on the stock. Analyst Commentary Recent Street research around AXA has been active, with several price target revisions and fresh initiations feeding into the updated fair value estimate.
User avatar
Narrative Update • Apr 22

CS: Technical And Fee-Based Earnings Mix Will Support Re-Rating As Discount Persists

Analysts have nudged their average price target for AXA slightly higher to about €46.07. This reflects modest tweaks to assumptions around discount rates, profit margins and future P/E multiples, alongside recent Street research that includes both upward and downward target revisions clustered around the €46 to €50 range.
User avatar
Narrative Update • Apr 07

CS: Technical And Fee-Based Earnings Shift Will Support Re-Rating As Discount Persists

AXA's analyst price targets have edged higher into a €46 to €50.70 range, as analysts point to improved profitability from technical insurance and fee-based earnings, along with what they view as an ongoing discount to European composite peers. Analyst Commentary Recent research points to a cluster of higher price targets for AXA, with analysts largely focused on the mix of technical insurance and fee-based earnings and how that feeds into profitability, earnings stability, and valuation relative to European peers.
User avatar
Narrative Update • Mar 24

CS: Technical And Fee-Based Shift Will Support Re-Rating As Discount Persists

Analysts have nudged AXA's average price target higher to around €48 to €51, citing improved profitability from its focus on technical insurance and fee-based earnings and pointing out that the current valuation still sits at a discount to European composite peers. Analyst Commentary Recent Street research has tilted positive on AXA, with several banks lifting their price targets into a relatively tight band between €46 and about €51.
User avatar
Narrative Update • Mar 10

CS: Technical And Fee-Based Shift Will Support Re-Rating Versus European Composite Peers

Our AXA fair value estimate has been adjusted from €45.27 to €46.05. This reflects higher analyst price targets in the €46 to €50.70 range and their focus on improved profitability, lower earnings volatility and a reduced P/E assumption.
User avatar
Narrative Update • Feb 23

CS: Technical And Fee-Based Shift Will Support Higher Future Earnings Multiple

Analysts have nudged their price target for AXA slightly higher to about €45.27 from roughly €45.11, citing continued focus on technical insurance and fee-based earnings that they say is supporting improved profitability and a higher assumed future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts point to the shift towards technical insurance and fee-based earnings as a key support for more stable and higher quality profit streams, which they see as supportive of a stronger P/E multiple over time.
User avatar
Narrative Update • Feb 08

CS: Slightly Lower Discount Rate Will Support Forward Earnings Appeal

The analyst fair value estimate for AXA has been adjusted slightly higher to €45.11 from €45.06, as analysts refine their assumptions around discount rates, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value Estimate adjusted slightly higher to €45.11 from €45.06.
User avatar
Narrative Update • Jan 24

CS: Stable Assumptions And Slightly Higher Required Return Will Support Forward Earnings Appeal

Analysts have slightly raised their fair value estimate for AXA to €45.06 from €44.98, citing adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a marginally higher price target. Valuation Changes Fair value estimate is now set at €45.06, up slightly from €44.98, reflecting a very small adjustment in the model.
User avatar
Narrative Update • Jan 10

CS: Stable Assumptions And Slightly Lower P/E Will Support Forward Earnings Appeal

Analysts have reduced their price target for AXA slightly to about €45, reflecting small adjustments to fair value estimates, discount rate assumptions and future P/E expectations, while keeping revenue growth and profit margin forecasts broadly unchanged. Valuation Changes Fair Value: Adjusted slightly from €45.07 to €44.98, indicating a very small reduction in the estimated fair value per share.
User avatar
Narrative Update • Dec 17

CS: Lower Discount Rate Will Support Stronger Forward Earnings Appeal

Analysts have nudged their price target on AXA slightly higher to approximately €45.07 from about €45.04, citing a marginally lower discount rate and modest improvements in projected profit margins that together support a slightly richer valuation multiple. Valuation Changes Fair Value has risen slightly from approximately €45.04 to about €45.07, reflecting a marginal uplift in the intrinsic valuation estimate.
User avatar
Narrative Update • Dec 03

CS: Modestly Higher Future Multiple Will Support Attractive Upside Potential

Analysts have modestly raised their price target on AXA to €45.04, citing a slightly higher assumed future price to earnings multiple, which more than offsets marginal adjustments to the discount rate and profit margin forecasts. Valuation Changes Fair Value Estimate unchanged at approximately €45.04 per share, indicating no revision to the intrinsic value assessment.
User avatar
Narrative Update • Nov 19

CS: Strong Profit Margins And Stable P/E Will Drive Future Gains

Analysts have slightly raised their price target for AXA, increasing it from €44.96 to €45.04. This change is based on modest adjustments to projected revenue growth, profit margins, and discount rates.
User avatar
Narrative Update • Nov 02

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

Analysts have slightly raised their price target for AXA from €44.58 to €44.96, citing incremental improvements in profit margin and expected future earnings multiples as key factors supporting the revision. Valuation Changes Fair Value has increased slightly from €44.58 to €44.96.
User avatar
New Narrative • Nov 07

Calculated Market Expansion And Innovative Products Drive Revenue Growth And Profitability

AXA's disciplined pricing and focus on operational excellence aim to enhance profitability in international markets.

Shareholder Returns

CSFR InsuranceFR Market
7D3.0%-0.1%-2.6%
1Y11.7%10.0%-1.7%

Return vs Industry: CS exceeded the French Insurance industry which returned 10% over the past year.

Return vs Market: CS exceeded the French Market which returned -1.7% over the past year.

Price Volatility

Is CS's price volatile compared to industry and market?
CS volatility
CS Average Weekly Movement1.8%
Insurance Industry Average Movement1.8%
Market Average Movement4.2%
10% most volatile stocks in FR Market8.8%
10% least volatile stocks in FR Market2.1%

Stable Share Price: CS has not had significant price volatility in the past 3 months compared to the French market.

Volatility Over Time: CS's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1852107,756Thomas Buberlwww.axa.com

AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through France, Europe, AXA XL, Asia, Africa & EME-LATAM, and Transversal & Other segments. It offers life and savings insurance and property and casualty insurance products.

AXA SA Fundamentals Summary

How do AXA's earnings and revenue compare to its market cap?
CS fundamental statistics
Market cap€88.25b
Earnings (TTM)€7.65b
Revenue (TTM)€96.79b
11.7x
P/E Ratio
0.9x
P/S Ratio

Is CS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CS income statement (TTM)
Revenue€96.79b
Cost of Revenue€82.42b
Gross Profit€14.38b
Other Expenses€6.72b
Earnings€7.65b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)3.78
Gross Margin14.85%
Net Profit Margin7.91%
Debt/Equity Ratio119.4%

How did CS perform over the long term?

See historical performance and comparison

Dividends

5.2%
Current Dividend Yield
62%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/16 17:40
End of Day Share Price 2026/09/16 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AXA SA is covered by 34 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Markus MayerBaader Helvea Equity Research
null nullBanco de Sabadell. S.A.
Valvanera Gómez PastorBanco Santander

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide